Progressive roll-out of the In Vitro Diagnostic Medical Devices Regulation
The In Vitro Diagnostic Medical Devices Regulation that will apply as from 26 May 2022, can now be progressively rolled out, thanks to its adoption by the European Parliament and the Council.
In the context of the COVID-19 pandemic Member States, health institutions and economic operators redeployed financial and other resources to address the unprecedented challenges of the crisis. By doing so, they delayed the implementation of the In Vitro Diagnostic Medical Devices Regulation of 2017, which introduced certain requirements for medical devices and a stronger role for so-called conformity assessment bodies. To prevent disruption of supply of essential healthcare products as a result of these delays, the Commission proposed in October a progressive roll-out of the Regulation of 2017. The adoption of this proposal by the co-legislators will keep the supply of these essential healthcare products flowing.
Welcoming the adoption, Commissioner for Health and Food Safety Stella Kyriakides yesterday said:
“In the midst of an unprecedented public health crisis, we cannot risk shortages of essential medical devices. Health systems and routine health services have been tested like never before. The pandemic has at the same time highlighted the vital need for accurate diagnostics and a resilient regulatory framework for in vitro medical devices. The amendment of the In Vitro Diagnostic Medical Devices Regulation will ensure that crucial medical devices, such as COVID or HIV tests, continue to be available and safe. Member States, manufacturers and notified bodies must now use the additional time to build up the necessary capacities, and manufacturers must prepare to transition to the new requirements. There is no time to rest.”
The amending Regulation does not change any requirements of the original In Vitro Diagnostic (IVD) Regulation of 2017. It only changes the dates of application of some of these requirements for certain medical devices.
For higher risk devices, such as HIV or hepatitis tests (class D), the new requirements will apply as from May 2025. For devices of the lower risk class C, such as certain influenza tests, the date of application is extended until May 2026, whilst for lower risk class devices (class B and A sterile), the application starts in May 2027.
Moreover, the application of certain requirements for devices manufactured and used in the same health institution (so-called ‘in-house devices') is delayed by two years until May 2024. If, however, the health institutions prove the unavailability of an equivalent device on the market, the transitional periods will end in May 2028.
Latest News from
Keynote speech by President von der Leyen at the opening ceremony of the Ukraine Recovery Conference05/07/2022 11:15:00
Keynote speech given yesterday by President von der Leyen at the opening ceremony of the Ukraine Recovery Conference.
European Commission proposes first €1 billion tranche of the new macro-financial assistance for Ukraine05/07/2022 09:25:00
The European Commission recently (01 July 2022) proposed a new €1 billion macro-financial assistance (MFA) operation for Ukraine as the first part of the exceptional MFA package of up to €9 billion announced in the Commission's communication of 18 May 2022 and endorsed by the European Council of 23-24 June 2022.
State aid: Commission approves €5 billion French scheme to support energy intensive companies in context of Russia's invasion of Ukraine04/07/2022 16:33:00
The European Commission has approved a €5 billion French scheme to support energy intensive companies across sectors in the context of Russia's invasion of Ukraine.
Consumer protection: Amazon Prime changes its cancellation practices to comply with EU consumer rules04/07/2022 15:25:00
Following a dialogue with the European Commission and national consumer protection authorities, Amazon has committed to bringing its cancellation practices in line with EU consumer rules.
Statement by President von der Leyen at the joint press conference with Prime Minister Fiala on the occasion of the College visit to the Czech Presidency04/07/2022 14:33:00
Statement given recently (01 July 2022) by President von der Leyen at the joint press conference with Prime Minister Fiala on the occasion of the College visit to the Czech Presidency.
Ukraine: Commission waives customs duties and VAT on the import of life-saving goods for Ukrainians04/07/2022 13:25:00
The European Commission recently (01 July 2022) adopted a Decision enabling Member States to temporarily waive customs duties and VAT on the importation from third countries of food, blankets, tents, electric generators and other life-saving equipment destined for Ukrainians affected by the war.
Digital finance: agreement reached on European crypto-assets regulation (MiCA)04/07/2022 12:38:00
The EU brings crypto-assets, crypto-assets issuers and crypto-asset service providers under a regulatory framework for the first time.
Foreign subsidies distorting the internal market: provisional political agreement between the Council and the European Parliament04/07/2022 11:33:00
The Council and the European Parliament recently (30 June 2022) reached a provisional political agreement on the regulation on foreign subsidies distorting the internal market.
State Aid: Commission opens in-depth investigation into Czech support for new nuclear power plant in Dukovany04/07/2022 10:38:00
The European Commission has opened an in-depth investigation to assess whether public support that Czechia plans to grant for the construction of a new nuclear power plant in Dukovany is in line with EU State aid rules.
Sanctions: Council requests European Parliament consent to add the violation of restrictive measures to the list of EU crimes04/07/2022 09:25:00
The Council recently (30 June 2022) requested the European Parliament’s consent on a decision to add the violation of restrictive measures to the list of ‘EU crimes’ included in the Treaty on the Functioning of the EU.